Fabrinet director receives 417 restricted share units as board compensation

Fabrinet director reports equity compensation grant.

Rhea-AI Filing Summary

Fabrinet director reports equity compensation grant. A Form 4 filing discloses that a director of Fabrinet received 417 restricted share units of the company’s ordinary shares on 12/11/2025 at a stated price of $0, reflecting a compensation award rather than an open-market purchase.

After this grant, the director beneficially owns 18,733 ordinary shares. The filing notes that each restricted share unit represents a contingent right to receive one ordinary share of Fabrinet stock, and the entire award is scheduled to vest on January 1, 2027, provided the director continues to serve on the board through that date.

Insider Trade Summary

Grant/Award: 417 shares

Grant/Award 1 txn

Insider Bahrami Homa

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Ordinary Shares	417	$0.00	$0.00

Holdings After Transaction: Ordinary Shares — 18,733 shares (Direct)

Footnotes (1)

1. F1. These are restricted share units awarded to the Reporting Person as partial compensation for serving on the Issuer's Board of Directors. Each restricted share unit represents a contingent right to receive one Ordinary Share of Issuer stock and will vest on January 1, 2027, provided the Reporting Person continues to serve through such date.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Fabrinet (FN) report in this Form 4?

The Form 4 reports that a Fabrinet director received 417 restricted share units of Fabrinet ordinary shares on 12/11/2025 as part of board compensation.

How many Fabrinet (FN) shares does the reporting person own after this transaction?

Following the reported grant, the director beneficially owns 18,733 ordinary shares of Fabrinet.

What are the terms of the Fabrinet (FN) restricted share units granted?

Each restricted share unit gives the director a contingent right to receive one ordinary share of Fabrinet stock, vesting on January 1, 2027 if the director continues to serve on the board through that date.

Was the Fabrinet (FN) director’s equity award an open-market purchase?

No. The filing describes the 417 restricted share units as compensation for serving on the board, with a reported price of $0 per unit, rather than a market transaction.

Does this Fabrinet (FN) Form 4 involve derivative securities like options or warrants?

The Form 4 includes a table for derivative securities, but the detailed entry provided relates to restricted share units that settle into ordinary shares, not options or warrants with a separate exercise price.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 12/12/2025 - 08:26 PM EST Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Bahrami Homa

(Last) (First) (Middle)

C/O FABRINET USA, INC.

3736 FALLON ROAD #428

(Street)

DUBLIN CA 94568

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Fabrinet [ FN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
12/11/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	12/11/2025		A		417(1)	A	$0	18,733	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. These are restricted share units awarded to the Reporting Person as partial compensation for serving on the Issuer's Board of Directors. Each restricted share unit represents a contingent right to receive one Ordinary Share of Issuer stock and will vest on January 1, 2027, provided the Reporting Person continues to serve through such date.

	Andrew Chew, Attorney-in-fact for Homa Bahrami	12/12/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.